Skip to content

VR for Steroid Joint Injections - Feasibility

Virtual Reality Implementation for Pain and Anxiety Management During Intra-articular Glucocorticoid Injections in a Pediatric Rheumatology Clinic

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07778069
Enrollment
10
Registered
2026-08-21
Start date
2026-08-20
Completion date
2029-12-01
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Juvenile Idiopahtic Arthritis, Procedural Anxiety

Keywords

Virtual Reality, VR, JIA, Rheumatology

Brief summary

The goal of the project is to implement virtual reality for pain and anxiety management for patients undergoing intra-articular glucocorticoid injections in the outpatient pediatric rheumatology clinic.

Detailed description

To assess feasibility of VR use in the clinic, 10 patients will be recruited to use VR during non-sedated intra-articular (IA) glucocorticoid injections. All patients will be offered our typical analgesia (LMX topical cream, freeze spray, lidocaine injection). Patients and caregivers will be asked to fill out pre-injection and post-injection surveys, and staff (rheumatology clinic nurses) will be asked for feedback regarding feasibility of VR in clinical workflows. The specific aims of the study are to: Aim 1: Assess the feasibility and efficacy of VR use to reduce pain in patients undergoing non-sedated IA glucocorticoid injections at Nationwide Children's Hospital

Interventions

OTHERVR-PAT

Virtual Reality Pain Alleviation Therapeutic (VR-PAT) via a Pico Neo3 Pro Eye

Sponsors

Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. rheumatology patients (5-17 years old) who are undergoing an IA glucocorticoid injection in the Nationwide Children's Rheumatology Clinic, 2. have a legal guardian present for patients less than 18 years old for the procedure (for informed consent), and 3. can communicate orally.

Exclusion criteria

1. any wounds that may interfere with study procedures, 2. vision, hearing, or cognitive/motor impairments preventing valid administration of study measures, 3. history of motion sickness, seizure disorder, dizziness, or migraine headaches precipitated by visual auras, 4. minors in foster care, 5. unable to communicate in English, 6. pregnant women, or 7. prisoners

Design outcomes

Primary

MeasureTime frameDescription
Practicality/utility of the VR experience as a pain and anxiety management tool for IA joint injection proceduresImmediately following the IA joint injection procedureAssessed by the nurse answering the following questions: "Is this distraction tool helpful during joint injection procedures (Yes/No)?" and "Is this distraction tool easy to use during joint injections (Yes/No)?"

Secondary

MeasureTime frameDescription
Self-reported change procedural anxietyImmediately before the IA joint injection procedure and immediately after0-10 Numerical Rating Scale (NRS) (self-reported), 0(min)-10(max), with higher score indicating worse anxiety.
Self-reported painImmediately following the IA joint injection procedure0-10 Numerical Rating Scale (NRS) (self-reported), 0(min)-10(max), with higher score indicating worse pain. Asked for worst pain, average pain, and time spent thinking about pain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026